E

EPIRUS Biopharmaceuticals

2 employees

Epirus Biopharmaceuticals develops biosimilar monoclonal antibodies and therapeutic proteins for emerging markets.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Therapeutics
Life Science

Date founded

2000

Funding rounds raised

Total raised

$36M

from 10 investors over 10 rounds

E

EPIRUS Biopharmaceuticals raised $36M on April 16, 2014

Investors: Mousse Partners, Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd., 5AM Ventures, Montreux Equity Partners, Gibralt Capital Corporation and Adage Capital Management

E

EPIRUS Biopharmaceuticals raised $5M on July 1, 2012

Investors: 5AM Ventures and Montreux Equity Partners

E

EPIRUS Biopharmaceuticals raised $8.1M on April 1, 2012

Investors: Montreux Equity Partners and 5AM Ventures

FAQ